Retraction: Plexin-B1 activates NF-κB and IL-8 to promote a pro-angiogenic response in endothelial cells (PLoS ONE (2011) 6: 10 (e25826) DOI: 10.1371/journal.pone.0025826);Plexin-B1 activates NF-κB and IL-8 to promote a pro-angiogenic response in endothelial cells

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Yang, Ying Hua ^a   Zhou, Hua ^a   Binmadi, Nada O ^a   Proia, Patrizia ^a,b   Basile, John R ^a,c  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^b UNIVERSITY OF PALERMO   (Italy)

^c UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CD31 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; PLEXIN; PLEXIN B1; PROTEIN INHIBITOR; PROTEIN KINASE B; RAS PROTEIN; RHO FACTOR; SEMAPHORIN; SEMAPHORIN 4D; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG; CD100 ANTIGEN; CELL SURFACE RECEPTOR; LEUKOCYTE ANTIGEN; NERVE PROTEIN; PLXNB1 PROTEIN, HUMAN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSCRIPTION FACTOR RELA;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CAPILLARY PROLIFERATION; CELL MATURATION; CELL MIGRATION; CELL NUCLEUS MEMBRANE; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CELL TRANSPORT; CHEMOTAXIS; CHIMERA; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; PHENOTYPIC VARIATION; PROTEIN FUNCTION; PROTEIN TARGETING; RNA INTERFERENCE; SIGNAL TRANSDUCTION; ANIMAL; CAPILLARY; CELL MOTION; CELL TRANSFORMATION; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; TUMOR CELL LINE; UMBILICAL VEIN ENDOTHELIAL CELL;

MUS MUSCULUS;

ANIMALS; ANTIGENS, CD; APOPTOSIS; CAPILLARIES; CELL LINE, TUMOR; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERLEUKIN-8; MICE; NEOVASCULARIZATION, PATHOLOGIC; NERVE TISSUE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, CELL SURFACE; RHOA GTP-BINDING PROTEIN; SEMAPHORINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA;

EID: 80054760663     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0223295     Document Type: Erratum

References (41)

1. Kolodkin AL, Matthes DJ, Goodman CS, (1993) The semaphorin genes encode a family of transmembrane and secreted growth cone guidance molecules. Cell 75: 1389-1399.
2. Giordano S, Corso S, Conrotto P, Artigiani S, Gilestro G, et al. (2002) The semaphorin 4D receptor controls invasive growth by coupling with Met. Nat Cell Biol 4: 720-724.
3. Conrotto P, Valdembri D, Corso S, Serini G, Tamagnone L, et al. (2005) Sema4D induces angiogenesis through Met recruitment by Plexin B1. Blood 105: 4321-4329.
4. Basile JR, Barac A, Zhu T, Guan KL, Gutkind JS, (2004) Class IV semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B. Cancer Res 64: 5212-5224.
5. Neufeld G, Shraga-Heled N, Lange T, Guttmann-Raviv N, Herzog Y, et al. (2005) Semaphorins in cancer. Front Biosci 10: 751-760.
6. Ch'ng ES, Kumanogoh A, (2010) Roles of Sema4D and Plexin-B1 in tumor progression. Mol Cancer 9: 251.
7. Ohta K, Mizutani A, Kawakami A, Murakami Y, Kasuya Y, et al. (1995) Plexin: a novel neuronal cell surface molecule that mediates cell adhesion via a homophilic binding mechanism in the presence of calcium ions. Neuron 14: 1189-1199.
8. Tamagnone L, Artigiani S, Chen H, He Z, Ming GI, et al. (1999) Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 99: 71-80.
9. Oinuma I, Ishikawa Y, Katoh H, Negishi M, (2004) The Semaphorin 4D receptor Plexin-B1 is a GTPase activating protein for R-Ras. Science 305: 862-865.
10. Tong Y, Chugha P, Hota PK, Alviani RS, Li M, et al. (2007) Binding of Rac1, Rnd1, and RhoD to a novel Rho GTPase interaction motif destabilizes dimerization of the plexin-B1 effector domain. J Biol Chem 282: 37215-37224.
11. Bishop AL, Hall A, (2000) Rho GTPases and their effector proteins. Biochem J 348 Pt 2: 241-255.
12. Kruger RP, Aurandt J, Guan KL, (2005) Semaphorins command cells to move. Nature Reviews Molecular Cell Biology 6: 789-800.
13. Hayden MS, Ghosh S, (2004) Signaling to NF-kappaB. Genes Dev 18: 2195-2224.
14. Gupta SC, Sundaram C, Reuter S, Aggarwal BB, (2010) Inhibiting NF-kappaB activation by small molecules as a therapeutic strategy. Biochim Biophys Acta 1799: 775-787.
15. Luqman S, Pezzuto JM, (2010) NFkappaB: a promising target for natural products in cancer chemoprevention. Phytother Res 24: 949-963.
16. Basile JR, Castilho RM, Williams VP, Gutkind JS, (2006) Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis. PNAS 103: 9017-9022.
17. Perrot V, Vazquez-Prado J, Gutkind JS, (2002) Plexin B regulates Rho through the guanine nucleotide exchange factors leukemia-associated Rho GEF (LARG) and PDZ-RhoGEF. J Biol Chem 277: 43115-43120.
18. Swiercz JM, Kuner R, Behrens J, Offermanns S, (2002) Plexin-B1 directly interacts with PDZ-RhoGEF/LARG to regulate RhoA and growth cone morphology. Neuron 35: 51-63.
19. Vikis HG, Li W, Guan KL, (2002) The plexin-B1/Rac interaction inhibits PAK activation and enhances Sema4D ligand binding. Genes Dev 16: 836-845.
20. Basile JR, Afkhami T, Gutkind JS, (2005) Semaphorin 4D/plexin-B1 induces endothelial cell migration through the activation of PYK2, Src, and the phosphatidylinositol 3-kinase-Akt pathway. Mol Cell Biol 25: 6889-6898.
21. Sakamoto K, Maeda S, Hikiba Y, Nakagawa H, Hayakawa Y, et al. (2009) Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth. Clin Cancer Res 15: 2248-2258.
22. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, et al. (1999) NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401: 82-85.
23. Kumanogoh A, Watanabe C, Lee I, Wang X, Shi W, et al. (2000) Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling. Immunity 13: 621-631.
24. Masuda K, Furuyama T, Takahara M, Fujioka S, Kurinami H, et al. (2004) Sema4D stimulates axonal outgrowth of embryonic DRG sensory neurones. Genes Cells 9: 821-829.
25. Basile JR, Gavard J, Gutkind JS, (2007) Plexin-B1 utilizes RhoA and Rho kinase to promote the integrin-dependent activation of Akt and ERK and endothelial cell motility. J Biol Chem 282: 34888-34895.
26. Romashkova JA, Makarov SS, (1999) NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 401: 86-90.
27. Rao SK, Pavicevic Z, Du Z, Kim JG, Fan M, et al. (2010) Pro-inflammatory genes as biomarkers and therapeutic targets in oral squamous cell carcinoma. J Biol Chem 285: 32512-32521.
28. Chen F, Demers LM, Shi X, (2002) Upstream signal transduction of NF-kappaB activation. Curr Drug Targets Inflamm Allergy 1: 137-149.
29. Karin M, Greten FR, (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5: 749-759.
30. Aurora AB, Biyashev D, Mirochnik Y, Zaichuk TA, Sanchez-Martinez C, et al. (2010) NF-kappaB balances vascular regression and angiogenesis via chromatin remodeling and NFAT displacement. Blood 116: 475-484.
31. Rice J, Courter DL, Giachelli CM, Scatena M, (2006) Molecular mediators of alphavbeta3-induced endothelial cell survival. J Vasc Res 43: 422-436.
32. Abdel-Malak NA, Srikant CB, Kristof AS, Magder SA, Di Battista JA, et al. (2008) Angiopoietin-1 promotes endothelial cell proliferation and migration through AP-1-dependent autocrine production of interleukin-8. Blood 111: 4145-4154.
33. Catalano A, Lazzarini R, Di Nuzzo S, Orciari S, Procopio A, (2009) The plexin-A1 receptor activates vascular endothelial growth factor-receptor 2 and nuclear factor-kappaB to mediate survival and anchorage-independent growth of malignant mesothelioma cells. Cancer Res 69: 1485-1493.
34. Ahmed ST, Darnell JE Jr, (2009) Serpin B3/B4, activated by STAT3, promote survival of squamous carcinoma cells. Biochem Biophys Res Commun 378: 821-825.
35. Sultana H, Neelakanta G, Kantor FS, Malawista SE, Fish D, et al. (2010) Anaplasma phagocytophilum induces actin phosphorylation to selectively regulate gene transcription in Ixodes scapularis ticks. J Exp Med 207: 1727-1743.
36. Sun Q, Zhou H, Binmadi NO, Basile JR, (2009) Hypoxia-inducible factor-1-mediated regulation of semaphorin 4D affects tumor growth and vascularity. J Biol Chem 284: 32066-32074.
37. Hannon GJ, Conklin DS, (2004) RNA interference by short hairpin RNAs expressed in vertebrate cells. Methods Mol Biol 257: 255-266.
38. Siolas D, Lerner C, Burchard J, Ge W, Linsley PS, et al. (2005) Synthetic shRNAs as potent RNAi triggers. Nat Biotechnol 23: 227-231.
39. Martin D, Galisteo R, Ji Y, Montaner S, Gutkind JS, (2008) An NF-kappaB gene expression signature contributes to Kaposi's sarcoma virus vGPCR-induced direct and paracrine neoplasia. Oncogene 27: 1844-1852.
40. Yang YH, Wu WK, Tai EK, Wong HP, Lam EK, et al. (2006) The cationic host defense peptide rCRAMP promotes gastric ulcer healing in rats. J Pharmacol Exp Ther 318: 547-554.
41. Amornphimoltham P, Sriuranpong V, Patel V, Benavides F, Conti CJ, et al. (2004) Persistent activation of the Akt pathway in head and neck squamous cell carcinoma: a potential target for UCN-01. Clin Cancer Res 10: 4029-4037.